Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engensis extension study in painful diabetic peripheral neuropathy
NCT04873232Phase 3Completed
- Sponsor
- Helixmith
- Start
- May 2021
- Primary completion
- Sep 2023
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 1
01
Overview
A Phase 3 trial of Engensis in diabetic peripheral neuropathy (DPN), sponsored by Helixmith. Started May 2021; status: completed.
02
Drugs
Engensis
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04873232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873232.